VANCOUVER, BC--(Marketwire - April 10, 2008) - Upstream Biosciences Inc. (OTCBB: UPBS) today announced the appointment of Jeffrey Bacha to its Board of Directors. Mr. Bacha has more than 15 years of experience in operations, strategy and finance in the life science industry, assisting biotechnology, pharmaceutical and medical device companies in the development and implementation of business and financing strategies for growth. Two of his companies were named “Top 10 Life Sciences Investment Opportunities” in Canada during every year of his tenure, and he was recognized by Business in Vancouver magazine as a “Top 40 Under 40" businessperson.
